FDA Approves JUVÉDERM® VOLBELLA® XC For Undereye Hollows
Go back to FDA Approves JUVÉDERM® VOLBELLA® XC For Undereye Hollows| AbbVie (NYSE: ABBV) | Delayed: 257.38 +1.90 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $255.48 | 52 Week High | $68.12 | |||
| Open | $254.17 | 52 Week Low | $50.71 | |||
| Day High | $257.42 | P/E | 55.83 | |||
| Day Low | $252.33 | EPS | $4.61 | |||
| Volume | 1,321,556 | |||||

